Login

Viorel Panait de la Comvex: Spotlight at Financial Intelligence's 2023 Capital Market Forum | Panait Viorel - CEO of Comvex 00:10:00

Share On Facebook Share On Twitter

Panait Viorel is the CEO of Comvex Constanta.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Bob Sulentic, CBRE Group CEO, and Lars Norell, Altus Power co-founder and co-CEO, discuss the decision to go public on "Squawk on the Street."
00:10:00
Scaling Sustainable Solutions: Ajay Discusses Electric Vehicle Battery Recycling and Profitability | Ajay Kochhar, CEO , Li-Cycle Holdings Corp.
00:10:00
Canaan is a long-time early stage investor|Brent Ahrens,General Partner,Canaan Partners
00:10:00
Breaking Through the Acquisition Barrier in Consumer, Gaming, and Marketplace Industries|Ben Mathews,General Partner, Night Ventures
00:10:00
Yuval Levin on Edmund Burke, Thomas Paine, and the Roots of Political Ideology
00:10:00
Michael Grecoff is interviewed | Peter Lenardos, CEO, Cinnober Financial Technology ABCINN:STO
00:10:00
Introducing Schwallier Wealth Management 1 | Adam Schwallier, President, Schwallier Wealth Management LLC.
00:10:00
House Majority Leader Kevin McCarthy: Roles and Responsibilities|Peter Robinson
00:10:00
Interview with Doug Gruer, CEO of Emu NL on Assay TV
00:10:00
"Insights into Strategic Asset Allocation: Evaluating BBVA Asset Management's Positioning from 2021 to 2022"
00:10:00
Catapult Limited CEO Will Lopes on 1H20 Results & Outlook | WILL LOPES - CHIEF EXECUTIVE OFFICER AND MANAGING DIRECTOR of Catapult Group International
00:10:00
Bellevue Gold: Rapid High-Grade Gold Discovery in Western Australia

© 2017 - Neuhu+